(R)-lipoic acid multiple interactions EXP 6480464 Thioctic Acid affects the reaction [Propylthiouracil results in increased expression of CALB2 mRNA] CTD PMID:31068541 1,2-dimethylhydrazine increases expression ISO RGD:1552967 6480464 1, 2-Dimethylhydrazine results in increased expression of CALB2 mRNA CTD PMID:22206623 17beta-estradiol affects expression ISO RGD:731363 6480464 Estradiol affects the expression of CALB2 mRNA CTD PMID:14699072 17beta-estradiol increases expression ISO RGD:731363 6480464 Estradiol results in increased expression of CALB2 mRNA CTD PMID:17121429 , PMID:17962382 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1552967 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1552967 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1552967 6480464 Tetrachlorodibenzodioxin affects the expression of CALB2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CALB2 mRNA CTD PMID:32109520 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2-hydroxypropanoic acid decreases expression ISO RGD:731363 6480464 Lactic Acid results in decreased expression of CALB2 mRNA CTD PMID:30851411 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of CALB2 mRNA CTD PMID:28522335 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:731363 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CALB2 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CALB2 mRNA CTD PMID:28628672 3-methylcholanthrene multiple interactions ISO RGD:731363 6480464 Methylcholanthrene promotes the reaction [AHR protein binds to CALB2 promoter] CTD PMID:20348232 5-fluorouracil increases response to substance ISO RGD:731363 6480464 CALB2 protein results in increased susceptibility to Fluorouracil CTD PMID:16510598 5-fluorouracil increases expression ISO RGD:731363 6480464 Fluorouracil results in increased expression of CALB2 mRNA CTD PMID:16510598 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of CALB2 mRNA CTD PMID:24780913 6-propyl-2-thiouracil multiple interactions EXP 6480464 Thioctic Acid affects the reaction [Propylthiouracil results in increased expression of CALB2 mRNA] CTD PMID:31068541 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CALB2 mRNA CTD PMID:31068541 aflatoxin B1 increases expression ISO RGD:731363 6480464 Aflatoxin B1 results in increased expression of CALB2 mRNA CTD PMID:32234424 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CALB2 mRNA CTD PMID:16483693 amphetamine increases expression ISO RGD:1552967 6480464 Amphetamine results in increased expression of CALB2 protein CTD PMID:19059431 arsane multiple interactions ISO RGD:731363 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CALB2 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:731363 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CALB2 mRNA CTD PMID:32525701 arsenous acid multiple interactions ISO RGD:731363 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CALB2 protein] CTD PMID:26598702 asbestos decreases expression ISO RGD:731363 6480464 Asbestos results in decreased expression of CALB2 mRNA CTD PMID:22076105 benzo[a]pyrene increases expression ISO RGD:731363 6480464 Benzo(a)pyrene results in increased expression of CALB2 mRNA CTD PMID:32234424 bis(2-ethylhexyl) phthalate increases expression ISO RGD:731363 6480464 Diethylhexyl Phthalate results in increased expression of CALB2 mRNA CTD PMID:31163220 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CALB2 mRNA CTD PMID:15901920 , PMID:25181051 bisphenol A increases expression ISO RGD:731363 6480464 bisphenol A results in increased expression of CALB2 protein CTD PMID:34186270 bisphenol A decreases expression ISO RGD:1552967 6480464 bisphenol A results in decreased expression of CALB2 mRNA CTD PMID:32156529 bisphenol A increases expression ISO RGD:1552967 6480464 bisphenol A results in increased expression of CALB2 mRNA, bisphenol A results in increased expression of CALB2 protein CTD PMID:32926169 bisphenol A decreases expression ISO RGD:731363 6480464 bisphenol A results in decreased expression of CALB2 mRNA CTD PMID:31715268 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CALB2 mRNA CTD PMID:31129395 bisphenol A increases methylation ISO RGD:1552967 6480464 bisphenol A results in increased methylation of CALB2 promoter CTD PMID:27312807 bisphenol A multiple interactions ISO RGD:731363 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CALB2 mRNA CTD PMID:28628672 Bisphenol B increases expression ISO RGD:731363 6480464 bisphenol B results in increased expression of CALB2 protein CTD PMID:34186270 bisphenol F multiple interactions ISO RGD:731363 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CALB2 mRNA CTD PMID:28628672 bisphenol F increases expression ISO RGD:731363 6480464 bisphenol F results in increased expression of CALB2 protein CTD PMID:34186270 Brodifacoum decreases expression EXP 6480464 bromfenacoum results in decreased expression of CALB2 protein CTD PMID:28903499 butanal increases expression ISO RGD:731363 6480464 butyraldehyde results in increased expression of CALB2 mRNA CTD PMID:26079696 Butylparaben increases expression ISO RGD:731363 6480464 butylparaben results in increased expression of CALB2 mRNA CTD PMID:17121429 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of CALB2 mRNA CTD PMID:19167457 cadmium atom increases expression ISO RGD:731363 6480464 Cadmium results in increased expression of CALB2 mRNA CTD PMID:21694771 carmustine decreases expression ISO RGD:731363 6480464 Carmustine results in decreased expression of CALB2 mRNA CTD PMID:15980968 cefaloridine decreases expression EXP 6480464 Cephaloridine results in decreased expression of CALB2 mRNA CTD PMID:18500788 CGP 52608 multiple interactions ISO RGD:731363 6480464 CGP 52608 promotes the reaction [RORA protein binds to CALB2 gene] CTD PMID:28238834 chlordecone increases expression ISO RGD:1552967 6480464 Chlordecone results in increased expression of CALB2 mRNA CTD PMID:33711761 copper(II) sulfate affects expression ISO RGD:731363 6480464 Copper Sulfate affects the expression of CALB2 mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO RGD:731363 6480464 Asbestos, Crocidolite results in decreased expression of CALB2 protein CTD PMID:21570478 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of CALB2 mRNA CTD PMID:26577399 cyclosporin A increases expression ISO RGD:731363 6480464 Cyclosporine results in increased expression of CALB2 mRNA CTD PMID:20106945 cytarabine decreases expression ISO RGD:731363 6480464 Cytarabine results in decreased expression of CALB2 mRNA CTD PMID:21198554 DDE multiple interactions EXP 6480464 Dichlorodiphenyl Dichloroethylene inhibits the reaction [Dietary Fats results in increased expression of CALB2 mRNA] CTD PMID:28572628 DDT increases expression EXP 6480464 DDT results in increased expression of CALB2 mRNA CTD PMID:30207508 dexamethasone multiple interactions ISO RGD:731363 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CALB2 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CALB2 mRNA CTD PMID:28628672 diarsenic trioxide multiple interactions ISO RGD:731363 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to CALB2 protein] CTD PMID:26598702 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of CALB2 mRNA CTD PMID:36653537 dorsomorphin multiple interactions ISO RGD:731363 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CALB2 mRNA CTD PMID:27188386 doxorubicin increases expression ISO RGD:731363 6480464 Doxorubicin results in increased expression of CALB2 mRNA CTD PMID:30031762 ethanol increases expression ISO RGD:1552967 6480464 Ethanol results in increased expression of CALB2 mRNA CTD PMID:30319688 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of CALB2 mRNA CTD PMID:35227807 flusilazole increases expression EXP 6480464 flusilazole results in increased expression of CALB2 mRNA CTD PMID:33032228 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of CALB2 mRNA CTD PMID:21525395 hydroquinone increases expression ISO RGD:731363 6480464 hydroquinone results in increased expression of CALB2 mRNA CTD PMID:31256213 indometacin multiple interactions ISO RGD:731363 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of CALB2 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CALB2 mRNA CTD PMID:28628672 ketamine increases expression EXP 6480464 Ketamine results in increased expression of CALB2 mRNA CTD PMID:20080153 ketoconazole decreases expression EXP 6480464 Ketoconazole results in decreased expression of CALB2 mRNA CTD PMID:36653537 L-ascorbic acid multiple interactions EXP 6480464 Ascorbic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of CALB2 protein] CTD PMID:31708536 lead diacetate multiple interactions EXP 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of CALB2 protein, Ascorbic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of CALB2 protein] CTD PMID:31708536 lead(0) affects expression ISO RGD:731363 6480464 Lead affects the expression of CALB2 mRNA CTD PMID:28903495 lead(0) multiple interactions EXP 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of CALB2 protein, Ascorbic Acid inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of CALB2 protein] CTD PMID:31708536 Licochalcone B increases expression ISO RGD:731363 6480464 licochalcone B results in increased expression of CALB2 mRNA CTD PMID:33647349 lipoic acid multiple interactions EXP 6480464 Thioctic Acid affects the reaction [Propylthiouracil results in increased expression of CALB2 mRNA] CTD PMID:31068541 maneb multiple interactions ISO RGD:1552967 6480464 [Maneb co-treated with Paraquat] results in decreased expression of CALB2 mRNA CTD PMID:36117858 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of CALB2 mRNA CTD PMID:28619521 methylisothiazolinone increases expression ISO RGD:731363 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of CALB2 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:731363 6480464 methylmercuric chloride results in increased expression of CALB2 mRNA CTD PMID:28001369 , PMID:34089799 methylparaben increases expression ISO RGD:731363 6480464 methylparaben results in increased expression of CALB2 mRNA CTD PMID:17121429 N-Nitrosopyrrolidine increases expression ISO RGD:731363 6480464 N-Nitrosopyrrolidine results in increased expression of CALB2 mRNA CTD PMID:32234424 nickel atom decreases expression ISO RGD:731363 6480464 Nickel results in decreased expression of CALB2 mRNA CTD PMID:25583101 O-methyleugenol increases expression ISO RGD:731363 6480464 methyleugenol results in increased expression of CALB2 mRNA CTD PMID:32234424 oxaliplatin increases response to substance ISO RGD:731363 6480464 CALB2 protein results in increased susceptibility to oxaliplatin CTD PMID:16510598 oxaliplatin increases expression ISO RGD:731363 6480464 oxaliplatin results in increased expression of CALB2 mRNA CTD PMID:16510598 ozone multiple interactions ISO RGD:1552967 6480464 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CALB2 mRNA CTD PMID:27106289 panobinostat increases expression ISO RGD:731363 6480464 panobinostat results in increased expression of CALB2 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:731363 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CALB2 mRNA CTD PMID:27188386 paraquat multiple interactions ISO RGD:1552967 6480464 [Maneb co-treated with Paraquat] results in decreased expression of CALB2 mRNA CTD PMID:36117858 PCB138 increases expression EXP 6480464 2 more ... CTD PMID:21673325 PCB138 multiple interactions ISO RGD:1552967 6480464 [2 more ... CTD PMID:25510870 pentanal increases expression ISO RGD:731363 6480464 pentanal results in increased expression of CALB2 mRNA CTD PMID:26079696 picrotoxin decreases expression EXP 6480464 Picrotoxin results in decreased expression of CALB2 protein CTD PMID:15382257 pirinixic acid increases expression ISO RGD:1552967 6480464 pirinixic acid results in increased expression of CALB2 mRNA CTD PMID:20813756 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of CALB2 mRNA CTD PMID:19162173 potassium dichromate increases expression ISO RGD:1552967 6480464 Potassium Dichromate results in increased expression of CALB2 mRNA CTD PMID:23608068 rac-lactic acid decreases expression ISO RGD:731363 6480464 Lactic Acid results in decreased expression of CALB2 mRNA CTD PMID:30851411 raloxifene increases expression ISO RGD:731363 6480464 Raloxifene Hydrochloride results in increased expression of CALB2 mRNA CTD PMID:17962382 rotenone affects expression ISO RGD:1552967 6480464 Rotenone affects the expression of CALB2 mRNA CTD PMID:23186747 SB 431542 multiple interactions ISO RGD:731363 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CALB2 mRNA CTD PMID:27188386 simvastatin decreases expression EXP 6480464 Simvastatin results in decreased expression of CALB2 protein CTD PMID:20217863 sodium arsenate multiple interactions ISO RGD:731363 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CALB2 mRNA CTD PMID:32525701 sodium arsenite affects methylation ISO RGD:731363 6480464 sodium arsenite affects the methylation of CALB2 gene CTD PMID:28589171 sodium arsenite increases expression ISO RGD:731363 6480464 sodium arsenite results in increased expression of CALB2 mRNA CTD PMID:34032870 sodium arsenite decreases expression ISO RGD:731363 6480464 sodium arsenite results in decreased expression of CALB2 mRNA CTD PMID:29301061 sodium arsenite affects expression ISO RGD:731363 6480464 sodium arsenite affects the expression of CALB2 mRNA CTD PMID:29319823 sotorasib multiple interactions ISO RGD:731363 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CALB2 mRNA CTD PMID:36139627 sterigmatocystin decreases expression EXP 6480464 Sterigmatocystin results in decreased expression of CALB2 mRNA CTD PMID:34126181 temozolomide decreases expression ISO RGD:731363 6480464 Temozolomide results in decreased expression of CALB2 mRNA CTD PMID:31758290 toluene increases expression EXP 6480464 Toluene results in increased expression of CALB2 mRNA CTD PMID:22967744 trametinib multiple interactions ISO RGD:731363 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CALB2 mRNA CTD PMID:36139627 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of CALB2 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:731363 6480464 trichostatin A results in increased expression of CALB2 mRNA CTD PMID:24935251 triclosan decreases expression ISO RGD:731363 6480464 Triclosan results in decreased expression of CALB2 mRNA CTD PMID:30510588 valproic acid increases expression ISO RGD:731363 6480464 Valproic Acid results in increased expression of CALB2 mRNA CTD PMID:24383497 more ...